We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LE icon
3401
Lands' End
LE
$384M
$38K ﹤0.01%
4,953
-11,184
-69% -$138K
LRMR icon
3402
Larimar Therapeutics
LRMR
$453M
$38K ﹤0.01%
11,822
+10,560
+837% +$26.5K
LUNG icon
3403
Pulmonx
LUNG
$104M
$38K ﹤0.01%
2,278
-2,974
-57% -$54.8K
MGTX icon
3404
MeiraGTx Holdings
MGTX
$1.25B
$38K ﹤0.01%
4,486
-3,626
-45% -$32K
OPRT icon
3405
Oportun Financial
OPRT
$355M
$38K ﹤0.01%
8,519
+2,291
+37% +$16.3K
RCKY icon
3406
Rocky Brands
RCKY
$356M
$38K ﹤0.01%
1,906
+176
+10% +$5.04K
SID icon
3407
Companhia Siderúrgica Nacional
SID
$1.17B
$38K ﹤0.01%
16,035
+2,338
+17% +$6.46K
ZVRA icon
3408
Zevra Therapeutics
ZVRA
$672M
$38K ﹤0.01%
6,041
-233
-4% -$1.32K
LUCK
3409
Lucky Strike Entertainment
LUCK
$949M
$38K ﹤0.01%
3,049
+911
+43% +$10.9K
SILV
3410
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$38K ﹤0.01%
6,911
+640
+10% +$3.78K
SHCR
3411
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$38K ﹤0.01%
19,904
-9,999
-33% -$17.5K
HRT
3412
DELISTED
HireRight Holdings Corporation
HRT
$38K ﹤0.01%
2,510
-374
-13% -$5.92K
VRAY
3413
DELISTED
ViewRay, Inc.
VRAY
$38K ﹤0.01%
10,593
-13,823
-57% -$46.4K
KEEL
3414
Keel Infrastructure Corp
KEEL
$2.17B
$37K ﹤0.01%
35,585
+32,925
+1,238% +$45K
BLBD icon
3415
Blue Bird Corp
BLBD
$2.05B
$37K ﹤0.01%
4,419
-1,041
-19% -$10.9K
CBL
3416
CBL Properties
CBL
$1.8B
$37K ﹤0.01%
1,445
-2,867
-66% -$81.9K
CCU icon
3417
Compañía de Cervecerías Unidas
CCU
$2.18B
$37K ﹤0.01%
3,432
+1,907
+125% +$21.1K
CDXS icon
3418
Codexis
CDXS
$171M
$37K ﹤0.01%
6,007
+3,433
+133% +$27.6K
CTMX icon
3419
CytomX Therapeutics
CTMX
$732M
$37K ﹤0.01%
25,728
+14,292
+125% +$22K
DCBO
3420
Docebo
DCBO
$584M
$37K ﹤0.01%
1,340
-3,292
-71% -$100K
DRTS icon
3421
Alpha Tau Medical
DRTS
$1.29B
$37K ﹤0.01%
+6,269
New +$55.3K
EBF icon
3422
Ennis
EBF
$559M
$37K ﹤0.01%
1,862
+1,190
+177% +$25.1K
EWTX icon
3423
Edgewise Therapeutics
EWTX
$4.8B
$37K ﹤0.01%
3,775
+2,555
+209% +$25.8K
EYPT icon
3424
EyePoint Inc
EYPT
$1.27B
$37K ﹤0.01%
4,605
+2,294
+99% +$21.3K
GAIN icon
3425
Gladstone Investment Corp
GAIN
$649M
$37K ﹤0.01%
3,046
+540
+22% +$7.76K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.